CFR 21 PART 200-299 : 2019

200 200.5 to 200.200 GENERAL 201 201.1 to 201.328 LABELING 202 202.1 PRESCRIPTION DRUG ADVERTISING 203 203.1 to 203.70 PRESCRIPTION DRUG MARKETING 205 205.1 to 205.50 GUIDELINES FOR STATE LICENSING OF WHOLESALE PRESCRIPTION DRUG DISTRIBUTORS 206 206.1 to 206.10 IMPRINTING OF SOLID ORAL DOSAGE FORM DRUG PRODUCTS FOR HUMAN USE 207 207.1 to 207.81 REQUIREMENTS FOR FOREIGN AND DOMESTIC ESTABLISHMENT REGISTRATION AND LISTING FOR HUMAN DRUGS, INCLUDING DRUGS THAT ARE REGULATED UNDER A BIOLOGICS LICENSE APPLICATION, AND ANIMAL DRUGS, AND THE NATIONAL DRUG CODE 208 208.1 to 208.26 MEDICATION GUIDES FOR PRESCRIPTION DRUG PRODUCTS 209 209.1 to 209.11 REQUIREMENT FOR AUTHORIZED DISPENSERS AND PHARMACIES TO DISTRIBUTE A SIDE EFFECTS STATEMENT 210 210.1 to 210.3 CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PROCESSING, PACKING, OR HOLDING OF DRUGS; GENERAL 211 211.1 to 211.208 CURRENT GOOD MANUFACTURING PRACTICE FOR FINISHED PHARMACEUTICALS 212 212.1 to 212.110 CURRENT GOOD MANUFACTURING PRACTICE FOR POSITRON EMISSION TOMOGRAPHY DRUGS 216 216.23 to 216.24 HUMAN DRUG COMPOUNDING 225 225.1 to 225.202 CURRENT GOOD MANUFACTURING PRACTICE FOR MEDICATED FEEDS 226 226.1 to 226.115 CURRENT GOOD MANUFACTURING PRACTICE FOR TYPE A MEDICATED ARTICLES 250 250.11 to 250.250 SPECIAL REQUIREMENTS FOR SPECIFIC HUMAN DRUGS 290 290.1 to 290.10 CONTROLLED DRUGS 299 299.3 to 299.5 DRUGS; OFFICIAL NAMES AND ESTABLISHED NAMES